NYSEARCA:VTAK • US74933X7084
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CATHETER PRECISION INC (VTAK).
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14K -36.36% | 442K 3,057.14% | 420K -4.98% | 3.876M 822.86% | 10.404M 168.42% | |
| EBITDA YoY % growth | -22.368M 19.25% | -15.11M 32.45% | -9.134M 39.55% | N/A | N/A | |
| EBIT YoY % growth | -22.789M 22.13% | -17.185M 24.59% | -11.243M 34.58% | -9.139M 18.71% | -6.487M 29.02% | |
| Operating Margin | -162,778.57% | -3,888.01% | -2,676.90% | -235.79% | -62.35% | |
| EPS YoY % growth | N/A | N/A | N/A -40.80% | -0.64 96.27% | -0.33 49.21% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 99.63% | -0.11 97.11% | -0.11 98.31% | -0.10 44.44% | -0.07 50.00% | -0.03 72.73% |
| Revenue Q2Q % growth | 1.224M 1,175.00% | 1.734M 1,063.76% | 1.632M 1,041.26% | 2.04M 862.26% | 2.856M 133.33% | 3.876M 123.53% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.183M 23.65% | -1.785M 41.49% | -2.275M 34.18% | -2.04M 28.12% | -1.52M 30.37% | -652.8K 63.43% |
All data in USD
7 analysts have analysed VTAK and the average price target is 38.76 USD. This implies a price increase of 2322.5% is expected in the next year compared to the current price of 1.6.
CATHETER PRECISION INC (VTAK) will report earnings on 2026-03-19, after the market close.
The consensus EPS estimate for the next earnings of CATHETER PRECISION INC (VTAK) is -0.14 USD and the consensus revenue estimate is 1.22M USD.